Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
Published August 3, 2016 · Recall initiated: May 18, 2016
Summary
FDA records drug Class III recall D-1449-2016, published August 3, 2016 and initiated May 18, 2016. Recalling firm: Teva North America; Status: Terminated; Reported quantity: 14, 370 units; Lot: Lot #: 02D163, Exp. 9/2017. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva North America
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: 02D163, Exp. 9/2017
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClaravis (isotretinoin capsules USP), 10mg, packaged in carton containing 3 Blister Packs of 10 Capsules EachOctober 12, 2016
- FDALinezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., NorthSeptember 14, 2016
- FDAARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary forSeptember 14, 2016
- FDAEptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only,September 14, 2016
- FDADextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by:August 3, 2016
- FDAOxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - For IV Use, Sterile,August 3, 2016
Questions about this recall
Was Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01. recalled?
Yes. FDA published recall D-1449-2016 on August 3, 2016. Reported hazard: Failed Tablet/Capsule Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter